Home › Funds › Two Sigma Investments › STRO
Two Sigma Investments position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)201.69K sh
Reported value held$6.70M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 227.48K | $4.30M | New |
| Q4 2021 | 113.08K | $1.68M | Reduce |
| Q1 2022 | 162.91K | $1.34M | Add |
| Q2 2022 | 182.90K | $953.00K | Add |
| Q3 2022 | 177.09K | $983.00K | Reduce |
| Q4 2022 | 237.90K | $1.92M | Add |
| Q1 2023 | 340.41K | $1.57M | Add |
| Q2 2023 | 135.82K | $631.54K | Reduce |
| Q4 2023 | 323.19K | $1.39M | New |
| Q1 2024 | 485.76K | $2.74M | Add |
| Q2 2024 | 503.60K | $1.48M | Add |
| Q3 2024 | 491.76K | $1.70M | Reduce |
| Q4 2024 | 316.29K | $581.98K | Reduce |
| Q1 2025 | 95.88K | $62.38K | Reduce |
| Q2 2025 | 115.07K | $82.15K | Add |
| Q3 2025 | 396.79K | $344.57K | Add |
| Q4 2025 | 46.49K | $537.91K | Reduce |
| Q1 2026 | 65.18K | $1.62M | Add |
| Q2 2026 | 201.69K | $6.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026